HIGHLIGHTS
- who: Miriam Ouadih-Moran and colleagues from the Department of Pediatrics, Torrevieja University Hospital, Alicante, Spain have published the research work: Is S100B Involved in Attention-Deficit/Hyperactivity Disorder (ADHD)? Comparisons with Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and -3 PUFAs, in the Journal: Nutrients 2023, 15, x FOR PEER REVIEW of /2023/
- what: In this dual three-month-phase clinical trial on children and adolescents with ADHD, the authors aimed at evaluating differences in serum S100B levels between ADHD patients and healthy controls; and_(2) assessing gradual changes in both . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.